Haleh Armian is the Director of Biomedical Innovation Ventures at Hoag Memorial Hospital Presbyterian in Newport Beach, CA. She leads Hoag’s CATALiST (Center for Accelerating Technology and Life Sciences Translation) which is a clinical and med-tech innovation hub partnering with industry, specifically early stage companies. The focus of Haleh’s work at Hoag Hospital is in Precision Medicine, Cancer, Neurosciences, Digital Pathology, AI. Over the span of her careers at Arthur D. Little, TIAX, CIMIT-Partners Healthcare, Joslin Diabetes Center, and Draper Laboratory, Haleh’s expertise is in working at the intersections of biomedical innovations, translational and outcomes research as well as medtech commercialization. Haleh received her Bachelor of Science degree at Boston College School of Management and her Master of Science degree at the Harvard School of Public Health.
Medical Innovation Exchange (MIx) is an organization of professionals and innovators in the medical technology industry. The goal of the organization is to foster curiosity and facilitate collaboration in healthcare. We provide a high energy, low stress environment for those looking to share knowledge and become part of a meaningful community.
Do you have a great company in the bioscience or medtech industry? Do you need wet-lab and/or fabrication space to develop and test your product?
